Galecto (GLTO) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now [Yahoo! Finance]
Galecto Reports Third Quarter 2024 Financial Results
Galecto, Inc. (NASDAQ: GLTO) had its price target raised by analysts at Oppenheimer Holdings Inc. from $9.00 to $10.00. They now have an "outperform" rating on the stock.
Galecto Strengthens Board of Directors with Appointment of Dr. Amy Wechsler
Galecto Completes Strategic Review to Focus on Oncology and Liver Disease and Acquires Acute Myeloid Leukemia Preclinical Asset from Bridge Medicines [Yahoo! Finance]